Related Experiment Video

Updated: Jun 16, 2025

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
07:25

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

6.8K

Unmet needs in the clinical management of chronic hepatitis B infection

Peter D Block1, Joseph K Lim1

  • 1Section of Digestive Diseases and Yale Liver Center, Yale School of Medicine, USA.

Journal of the Formosan Medical Association = Taiwan Yi Zhi
|August 18, 2024
PubMed

Insights

Hepatitis B virus (HBV) care faces challenges despite available tools. This review addresses optimizing perinatal care, improving liver cancer risk models, and defining finite therapy for chronic hepatitis B patients.

Area of Science:

  • Hepatology and Viral Gastroenterology
  • Infectious Diseases and Public Health

Background:

  • Hepatitis B virus (HBV) infection is a significant global health concern.
  • Despite advancements, challenges persist in the clinical care cascade for chronic HBV patients.
  • Effective prevention, diagnosis, and control tools exist but are not fully optimized.

Purpose of the Study:

  • To review critical and timely clinical issues in hepatitis B virus (HBV) management.
  • To focus on optimizing perinatal HBV care delivery.
  • To enhance HBV-related hepatocellular carcinoma (HCC) risk stratification and clarify finite therapy's role.

Main Methods:

  • This is a review article, synthesizing current knowledge and recent developments.
  • Focuses on analyzing key clinical challenges and potential solutions in HBV care.
  • Literature review and expert synthesis of advancements in three specific HBV clinical areas.

Main Results:

  • Optimizing perinatal HBV care is crucial for preventing transmission.
  • Improved models for stratifying hepatocellular carcinoma (HCC) risk in HBV patients are needed.
  • The role and efficacy of finite therapy within the HBV treatment algorithm require further clarification.

Conclusions:

  • Addressing unmet needs in the HBV care cascade is essential for improved patient outcomes.
  • Further investigation and optimization of perinatal care, HCC risk models, and finite therapy are warranted.
  • Advancements in these areas aim to motivate enhanced HBV treatment strategies.

More Related Videos

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

2.2K
Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle09:35

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle

Published on: February 1, 2017

13.2K

Related Concept Videos

Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
79
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
57
Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
113
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
427
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
192
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
124